-0.9 C
London
Saturday, December 2, 2023

Emerging Growth Conference 65 December 6 & 7 - Register now

More Headlines

Epazz Holdings (OTC Pink: EPAZ) Partnerships with UAE and Saudi Arabia...

ZenaDrone working to Establish New Partnerships with UAE and Saudi Arabia Companies at the Dubai Air Show See the full release at: https://emerginggrowth.com/profile/epaz/ CHICAGO, November 15,...

12 Best Bitcoin Mining Software for Windows PC

With the advent of blockchain technology, hundreds of different cryptocurrencies have appeared. Today, mining is available to almost everyone. Just make sure your computer...

AD-214 RETURNS TO CLINICAL STUDIES

Key points: First dosing of AD-214 achieved in Phase I extension study On track to obtain interim results in 2023, full results in...

Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD)

Unlocking Chronic Diseases with Next-Gen i-body Platform Technology from AdAlta (1AD) 1AD stock carries a dramatically undervalued profile against its blue-sky upside target Emerging Growth Report...

Epazz, Inc. (OTC Pink: EPAZ) Tokens, Funding for over $2 million...

Epazz, Inc. (OTC Pink: EPAZ) a mission-critical provider of drone technology, blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that CryObo...

$1.87 million raised in oversubscribed Shortfall facility

MELBOURNE Australia, 13 July 2023: AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform is pleased...

New AD-214 Data Links Phase I Results With Efficacy; De-Risks Clinical Dosing Schedule

Key points: • New data favourably links AD-214 preclinical animal studies and Phase I human clinical trial results to provide important dose frequency insights • AD-214 is designed to...

AdAlta (ASX: 1AD) IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED

29 June 2023 ASX Announcement IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED Key highlights: Human Research Ethics Committee (HREC) has approved Phase I extension...

Understanding the Different Approaches in Investing in Cryptocurrency

The cryptosphere, teeming with opportunity and complexity, is redefining the boundaries of traditional investing. Cryptocurrencies, which were once the obscure fascination of technophiles, have...

A Case Study: Reborn Coffee Inc. (NASDAQ: REBN)

America may run on Dunkin, but before you know it, Americans may soon be running for a sip of perfectly crafted cold brew coffee...